96E-18826-28650
1 vaccination
2 coded responses
3 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 741 / OK
- Registered
- 2021-03-11
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-25
Dose 1 — Moderna
-
2021-03-11
Registered in v-safe
-
2021-03-11
Survey response — day 14, dose 1MedDRA: Injection site discolouration, Injection site pain, Injection site pruritus, Injection site rash, Injection site swelling, Injection site urticaria, Rash erythematous — Feeling: FairFree text: Rash at injection site 8 days following the injection. Approximately 2 x 3 inches. Began as red bumps, spread into large red area, became red ring. Also developed brown, scaly spot presumably where shot was administered. Itchy, swollen, sore.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-18
-
2021-08-26
Survey response — 6 months, dose 1MedDRA: Diffuse alopecia, Injection site rash, Menstruation irregular — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: I continue to have rashes at and near to my injection sites. I have also experienced menstrual changes and telogen effluviums directly following both vaccines.MedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-26
Report sent to call center — 6 months, dose 1Get care from a doctor or other healthcare professional1 call case(s)
- 2021-09-01
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-25 | Moderna |
Call center
1 call center case
1 unsuccessful
VAERS report filed, before or during a call: 1
Free text
Release 5 — day 14, dose 1
Symptoms: Rash at injection site 8 days following the injection. Approximately 2 x 3 inches. Began as red bumps, spread into large red area, became red ring. Also developed brown, scaly spot presumably where shot was administered. Itchy, swollen, sore.
Release 9 — 6 months, dose 1
Symptoms: I continue to have rashes at and near to my injection sites. I have also experienced menstrual changes and telogen effluviums directly following both vaccines.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Diffuse alopecia | ✓ | · | ✓ |
| SD | Injection site discolouration | ✓ | ✓ | ✓ |
| SD | Injection site pain | ✓ | ✓ | ✓ |
| SD | Injection site pruritus | ✓ | ✓ | ✓ |
| SD | Injection site rash | ✓ | ✓ | ✓ |
| SD | Injection site swelling | ✓ | ✓ | ✓ |
| SD | Injection site urticaria | ✓ | ✓ | ✓ |
| SD | Menstruation irregular | ✓ | · | ✓ |
| SD | Rash erythematous | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release